Author(s): Henderson MT, Hollmig ST
Malignant fibrous histiocytoma (MFH) is a rare neoplasm exhibiting a propensity for aggressive clinical behavior. This review seeks to provide the practicing dermatologist with a contemporary understanding of MFH in order to guide management decisions. An extensive review of the literature was conducted using PubMed and OVID databases, searching for articles regarding MFH and undifferentiated pleomorphic sarcoma. The modern conception of MFH has changed extensively from clinical and pathologic standpoints. Limitations of the study included the reliability of past studies given the changing nature of MFH as a diagnostic entity. MFH represents an aggressive neoplasm with unique molecular, immunohistochemical, and behavioral characteristics. Practicing clinicians would benefit from a contemporary understanding of these tumors, particularly as a discussion of advances in the conception of MFH is largely absent in the dermatologic literature.
Referred From: https://www.jaad.org/article/S0190-9622(12)00436-7/abstract
Author(s): Metaxas G, Tangalos A, Pappa P, Papageorgiou I
Author(s): Pithawa AK, Bansal AS, Kochar SPS
Author(s): Saviano MS, Fundaro S, Gelmini R, Begossi G, Perrone S, et al.
Author(s): de Perrot M, Bründler MA, Tötsch M, Mentha G, Morel P
Author(s): Sheth S, Horton KM, Garland MR, Fishman EK
Author(s): Liles JS, Tzeng CWD, Short JJ, Kulesza P, Heslin MJ
Author(s): Diaz-Beveridge R, Melian M, Zac C, Navarro E, Akhoundova D, et al.
Author(s): Kim HS, Young Kim G, Lim SJ
Author(s): Prakash A, Agrawal A, Gupta RK, Sanghvi B, Parelkar S
Author(s): Folpe AL, Morris RJ, Weiss SW
Author(s): O’Connell JX, Wehrli BM, Nielsen GP
Author(s): Oliveira AM, Dei Tos AP, Fletcher CD, Nascimento AG
Author(s): Remstein ED, Arndt CA, Nascimento AG
Author(s): Zelger B, Weinlich G, Steiner H, Zelger BG, Egarter-Vigl E
Author(s): Lehnhardt M, Daigeler A, Homann HH, Schwaiberger V, Goertz O, et al.